Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Retrospective Observational Study of Atypical Winter Respiratory Illness Season Using Real-Time Syndromic Surveillance, England, 2014-15.

Smith S, Morbey R, Pebody RG, Hughes TC, de Lusignan S, Yeates FA, Thomas H, O'Brien SJ, Smith GE, Elliot AJ.

Emerg Infect Dis. 2017 Nov;23(11):1834-1842. doi: 10.3201/eid2311.161632.

2.

Detecting a Surprisingly Low Transmission Distance in the Early Phase of the 2009 Influenza Pandemic.

Marziano V, Pugliese A, Merler S, Ajelli M.

Sci Rep. 2017 Sep 26;7(1):12324. doi: 10.1038/s41598-017-12415-2.

3.

Projecting social contact matrices in 152 countries using contact surveys and demographic data.

Prem K, Cook AR, Jit M.

PLoS Comput Biol. 2017 Sep 12;13(9):e1005697. doi: 10.1371/journal.pcbi.1005697. eCollection 2017 Sep.

4.

Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.

Jain VK, Bhashini N, Balajee LK, Sistla S, Parija SC, Negi VS.

Indian J Med Res. 2017 Apr;145(4):464-470. doi: 10.4103/ijmr.IJMR_920_15.

5.

When treating rheumatoid arthritis be vigilant for influenza (& pneumonia): Don't ignore, don't neglect.

Chopra A, Joshi VL.

Indian J Med Res. 2017 Apr;145(4):420-423. doi: 10.4103/ijmr.IJMR_62_17. No abstract available.

6.

Structure of general-population antibody titer distributions to influenza A virus.

Nhat NTD, Todd S, de Bruin E, Thao TTN, Vy NHT, Quan TM, Vinh DN, van Beek J, Anh PH, Lam HM, Hung NT, Thanh NTL, Huy HLA, Ha VTH, Baker S, Thwaites GE, Lien NTN, Hong TTK, Farrar J, Simmons CP, Chau NVV, Koopmans M, Boni MF.

Sci Rep. 2017 Jul 20;7(1):6060. doi: 10.1038/s41598-017-06177-0.

7.

Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.

Nasreen S, Rahman M, Hancock K, Katz JM, Goswami D, Sturm-Ramirez K, Holiday C, Jefferson S, Branch A, Wang D, Veguilla V, Widdowson MA, Fry AM, Brooks WA.

Influenza Other Respir Viruses. 2017 Sep;11(5):394-398. doi: 10.1111/irv.12462. Epub 2017 Jul 26.

8.

The impact of stratified immunity on the transmission dynamics of influenza.

Yuan HY, Baguelin M, Kwok KO, Arinaminpathy N, van Leeuwen E, Riley S.

Epidemics. 2017 Sep;20:84-93. doi: 10.1016/j.epidem.2017.03.003. Epub 2017 Mar 12.

9.

Rethinking thresholds for serological evidence of influenza virus infection.

Zhao X, Siegel K, Chen MI, Cook AR.

Influenza Other Respir Viruses. 2017 May;11(3):202-210. doi: 10.1111/irv.12452. Epub 2017 Apr 26.

10.

Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.

Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, Bantar C, Dubnov-Raz G, Gérardin P, Koay ESC, Loh TP, Memish Z, Miller E, Oliva ME, Rath BA, Schweiger B, Tang JW, Tran D, Vidmar T, Waight PA, Nguyen-Van-Tam JS.

Clin Infect Dis. 2017 May 15;64(10):1328-1334. doi: 10.1093/cid/cix127.

11.

Study on age-dependent pre-existing 2009 pandemic influenza virus T and B cell responses from Chinese population.

Lv J, Ren ZY, Zhang YY, Liu YE, Gao J, Yao K, Feng D, Li ZY, Feng X, Liu YX, Jia N.

BMC Infect Dis. 2017 Feb 10;17(1):136. doi: 10.1186/s12879-017-2215-1.

12.

Human mobility and the spatial transmission of influenza in the United States.

Charu V, Zeger S, Gog J, Bjørnstad ON, Kissler S, Simonsen L, Grenfell BT, Viboud C.

PLoS Comput Biol. 2017 Feb 10;13(2):e1005382. doi: 10.1371/journal.pcbi.1005382. eCollection 2017 Feb.

13.

School closure policies at municipality level for mitigating influenza spread: a model-based evaluation.

Ciavarella C, Fumanelli L, Merler S, Cattuto C, Ajelli M.

BMC Infect Dis. 2016 Oct 18;16(1):576.

14.

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ.

Am J Epidemiol. 2016 Sep 1;184(5):345-53. doi: 10.1093/aje/kww064.

15.
16.

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.

Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm-Ramirez K, Sanchez JL, Katz JM, Uyeki TM, Wood J, Van Kerkhove MD; CONSISE Steering Committee.

Influenza Other Respir Viruses. 2017 Jan;11(1):2-14. doi: 10.1111/irv.12411. Epub 2016 Aug 9.

17.

Reconstructing a spatially heterogeneous epidemic: Characterising the geographic spread of 2009 A/H1N1pdm infection in England.

Birrell PJ, Zhang XS, Pebody RG, Gay NJ, De Angelis D.

Sci Rep. 2016 Jul 11;6:29004. doi: 10.1038/srep29004.

18.

Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.

Yaari R, Katriel G, Stone L, Mendelson E, Mandelboim M, Huppert A.

J R Soc Interface. 2016 Mar;13(116). pii: 20160099. doi: 10.1098/rsif.2016.0099.

19.

Quantifying homologous and heterologous antibody titre rises after influenza virus infection.

Freeman G, Perera RA, Ngan E, Fang VJ, Cauchemez S, Ip DK, Peiris JS, Cowling BJ.

Epidemiol Infect. 2016 Aug;144(11):2306-16. doi: 10.1017/S0950268816000583. Epub 2016 Mar 28.

20.

Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.

Van Effelterre T, Dos Santos G, Shinde V.

PLoS One. 2016 Mar 24;11(3):e0151575. doi: 10.1371/journal.pone.0151575. eCollection 2016.

Supplemental Content

Support Center